IOSP — Innospec Income Statement
0.000.00%
Last trade - 00:00
- $3.04bn
- $2.84bn
- $1.95bn
- 96
- 45
- 96
- 93
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,513 | 1,193 | 1,483 | 1,964 | 1,949 |
Cost of Revenue | |||||
Gross Profit | 466 | 343 | 435 | 587 | 591 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,363 | 1,159 | 1,351 | 1,776 | 1,787 |
Operating Profit | 150 | 33.7 | 132 | 187 | 162 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 150 | 39.7 | 134 | 185 | 174 |
Provision for Income Taxes | |||||
Net Income After Taxes | 112 | 28.7 | 93.1 | 133 | 139 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 112 | 28.7 | 93.1 | 133 | 139 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 112 | 28.7 | 93.1 | 133 | 139 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.54 | 2.49 | 3.81 | 5.42 | 6.01 |
Dividends per Share |